SMTL ID : 2y3a.1

Crystal structure of p110beta in complex with icSH2 of p85beta and the drug GDC-0941

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.30 Å

Oligo State

hetero-1-1-mer

Ligands

1 x GD9: 2-(1H-indazol-4-yl)-6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-yl-thieno[3,2-d]pyrimidine(Non-covalent)

GD9.1: 12 residues within 4Å: Chain A: Y.800, M.801, D.802, D.835, Y.861, I.873, E.874, V.875, V.876, M.948, I.958, D.959 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:D.802, A:D.835, A:V.876 Salt bridges: A:D.802, A:D.884

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, X. et al., Structure of Lipid Kinase P110Beta-P85Beta Elucidates an Unusual Sh2-Domain-Mediated Inhibitory Mechanism. Mol.Cell (2011)

Release Date

2011-03-16

Peptides

PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT BETA ISOFORM: A
PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY SUBUNIT BETA: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT BETA ISOFORM

PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY SUBUNIT BETA